Appropriateness of Prescribing Rivaroxaban at King Khalid University Hospital Riyadh
Background and aim Warfarin is recognized as a first-line treatment for different coagulopathy conditions; however, guidelines also encourage the use of rivaroxaban as an alternative option. The recent approval of the novel oral anticoagulants (NOACs) has led to swift changes in anticoagulant prescr...
Gespeichert in:
Veröffentlicht in: | Curēus (Palo Alto, CA) CA), 2022-01, Vol.14 (1), p.e20977-e20977 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!